Please take a tour of our Berlin EPCU site.
Other content in this Stream
4:24Hear firsthand from Monica about her personal journey as a clinical trial participant to understand the value of easing patient burden
2:55James Anthony, SVP, Global Head Biotech and Graciela Rácaro, SVP, Global Head, Biotech Operations, both from Parexel, discuss how Parexel Biotech has been built to meet customer and patient needs
Learn about five economical and efficient ways to make early phase trials both patient-centric and more effective.
Learn about five steps that will help companies better manage the complexity and risk of working with targeted medicines.
For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.
Learn more about new regulatory frameworks for precision medicine and how best to demonstrate results for regulatory bodies.
2:15Parexel’s Leanne Larson, Corporate VP and WW Head, Real-world Evidence speaks with Deborah Collyar, cancer survivor and President of Advocates in Research about the importance of Real-world Evidence (
2:53Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
Learn more about what to look for in the right CRO partner to overcome logistical and operational challenges in cell and gene therapy product development.
In this blog, Parexel regulatory and strategy experts tackle the question of how we can ensure that worthy innovations in the biotech pipeline make it to patients sooner.
In this on-demand webinar, Parexel experts discuss the growing interest in RWE from both regulators and payors and the advantages of using real-world data (RWD) to streamline the research process.
Let us show you how our experience of leveraging real-world data (RWD) and real-world evidence (RWE) can help your product launch succeed.